Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Atypical Spinal Muscular Atrophy Advanced Sequencing Evaluation Athena Diagnostics United States | 10 | 10 |
|
CMT Advanced Evaluation - Nonprevalent Athena Diagnostics United States | 25 | 21 |
|
Charcot-Marie-Tooth neuropathy type 2C Bioarray Spain | 1 | 1 |
|
CeGaT GmbH Germany | 9 | 1 |
|
Spinal Muscular Atrophy (SMA) Panel CeGaT GmbH Germany | 44 | 27 |
|
Charcot-Marie-Tooth and Sensory Neuropathies Panel CeGaT GmbH Germany | 63 | 84 |
|
Hereditary Spastic Paraplegias (HSP) and differential diagnoses Panel CeGaT GmbH Germany | 147 | 143 |
|
Fulgent Genetics United States | 10 | 1 |
|
Charcot Marie Tooth Disease Extended NGS Panel Fulgent Genetics United States | 172 | 59 |
|
Distal Hereditary Motor Neuropathy NGS Panel Fulgent Genetics United States | 38 | 15 |
|
Fulgent Genetics United States | 542 | 178 |
|
Athena Diagnostics United States | 1 | 1 |
|
CMT Advanced Evaluation - Axonal Athena Diagnostics United States | 20 | 13 |
|
CMT Advanced Evaluation - Comprehensive Athena Diagnostics United States | 31 | 23 |
|
CMT Advanced Evaluation - Dominant, Axonal Athena Diagnostics United States | 15 | 11 |
|
CMT Advanced Evaluation - Dominant Athena Diagnostics United States | 18 | 13 |
|
Asper Biogene Asper Biogene LLC Estonia | 166 | 74 |
|
Fulgent Genetics United States | 5124 | 4672 |
|
Fulgent Genetics United States | 258 | 112 |
|
Hereditary Neuropathies NGS Panel Fulgent Genetics United States | 91 | 38 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.